⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

TG Therapeutics, Inc.

$56.20
+0.36 (+0.64%)

Volume:

903.838K ($50.87M)

Market Capitalization:

$8.60B

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

TG Therapeutics Market Segments

Regular Trading Hours

-1.41(-2.45%)
Open$57.61
Close$56.20
Low$56.04
Low Change-1.57 (-2.73%)
High$57.87
High Change+0.26 (+0.45%)
Range$1.83
Volume862.075K
Dollar Volume$48.45M

Premarket

+2.38(+4.28%)
Open$55.55
Close$57.93
Low$55.55
Low Change0.00 (0.00%)
High$57.93
High Change+2.38 (+4.28%)
Range$2.38
Volume41.763K
Dollar Volume$2.42M

Overnight

*No Trades in Segment

After Hours Yesterday

+0.09(+0.16%)
Open$55.85
Close$55.94
Low$55.82
Low Change-0.03 (-0.05%)
High$55.94
High Change+0.09 (+0.16%)
Range$0.12
Volume307.518K
Dollar Volume$17.20M

Regular Trading Hours Yesterday

+2.72(+5.12%)
Open$53.12
Close$55.84
Low$53.11
Low Change-0.02 (-0.03%)
High$57.61
High Change+4.49 (+8.44%)
Range$4.50
Volume2.033M
Dollar Volume$113.50M

Premarket Yesterday

+0.10(+0.19%)
Open$53.11
Close$53.21
Low$52.95
Low Change-0.16 (-0.30%)
High$53.21
High Change+0.10 (+0.19%)
Range$0.26
Volume1.079K
Dollar Volume$57.41K

TG Therapeutics Top Trades

TG Therapeutics's top trade so far today returned +4.28%, while the top short trade returned -3.26%.

TG Therapeutics Moving Averages

5 Day Moving Average (SMA5)$54.45
10 Day Moving Average (SMA10)$55.23
20 Day Moving Average (SMA20)$54.77
50 Day Moving Average (SMA50)$53.51
100 Day Moving Average (SMA100)$48.75
200 Day Moving Average (SMA200)$39.82

TG Therapeutics Statistics

Average Volume (30 Days)1.86M
P/E Ratio (Current)18.42
EPS (Current)$2.88
Dividend Yield0.00%
Free Cash Flow$17.39M
Cash Ratio1.80
Current Ratio4.27
Quick Ratio3.72
Debt to Equity1.23
Enterprise Value$8.38B
EV to EBITDA61.43
EV to Sales10.48
Price to Book13.44
Price to Cash Flow454.17
Price to Free Cash Flow467.00
Price to Sales10.15
Return on Assets0.27%
Return on Equity0.73%

TG Therapeutics Stock Splits

There has been 1 stock split for TG Therapeutics (TGTX). The reverse stock split occured on April 30, 2012 and reduced the outstanding shares at a ratio of 56.25:1.

DateTypeRatio
Apr 30, 2012Reverse56.25:1

TG Therapeutics Dividends

There have been no dividends for TG Therapeutics (TGTX).